In this issue:
Placebo responses in pharmacological IBS trials
Low-dose aspirin, mesalazine or both in familial adenomatous polyposis
PPI response in eosinophilic oesophagitis is associated with impedance-pH parameters
Persistent villous atrophy in de novo coeliac disease with gluten-free diet
Comparative efficacy and safety of first-line H. pylori eradication therapies
Regular PPI use increases type 2 diabetes risk
PPIs increase risk of fatty liver disease
Vonoprazan vs. lansoprazole for artificial gastric ulcers
Haemoclips for preventing delayed postpolypectomy bleeding
Please login below to download this issue (PDF)